Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Conference News EuroPCR 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Caitlin E. Cox

May 20, 2024

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

News Daily News

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

Caitlin E. Cox

September 18, 2023

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Daily News

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Michael O'Riordan

October 28, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Conference News EuroPCR 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

Caitlin E. Cox

June 26, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

Advertisement

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

TCTMD’s Top 10 Most Popular Stories for August 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

TCTMD’s Top 10 Most Popular Stories for October 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content